Literature DB >> 27492620

Physiological functions and clinical implications of the N-end rule pathway.

Yujiao Liu1,2, Chao Liu2,3, Wen Dong4, Wei Li5.   

Abstract

The N-end rule pathway is a unique branch of the ubiquitin-proteasome system in which the determination of a protein's half-life is dependent on its N-terminal residue. The N-terminal residue serves as the degradation signal of a protein and thus called N-degron. N-degron can be recognized and modifed by several steps of post-translational modifications, such as oxidation, deamination, arginylation or acetylation, it then polyubiquitinated by the N-recognin for degradation. The molecular basis of the N-end rule pathway has been elucidated and its physiological functions have been revealed in the past 30 years. This pathway is involved in several biological aspects, including transcription, differentiation, chromosomal segregation, genome stability, apoptosis, mitochondrial quality control, cardiovascular development, neurogenesis, carcinogenesis, and spermatogenesis. Disturbance of this pathway often causes the failure of these processes, resulting in some human diseases. This review summarized the physiological functions of the N-end rule pathway, introduced the related biological processes and diseases, with an emphasis on the inner link between this pathway and certain symptoms.

Entities:  

Keywords:  Ate1; Johanson–Blizzard syndrome; N-end rule pathway; cardiovascular development; neurodegenerative disorders; neurogenesis; spermatogenesis

Mesh:

Substances:

Year:  2016        PMID: 27492620     DOI: 10.1007/s11684-016-0458-7

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  141 in total

Review 1.  The ubiquitin-proteasome pathway and pathogenesis of human diseases.

Authors:  A L Schwartz; A Ciechanover
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

2.  Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast.

Authors:  F Uhlmann; D Wernic; M A Poupart; E V Koonin; K Nasmyth
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

Review 3.  The structure and function of SMC and kleisin complexes.

Authors:  Kim Nasmyth; Christian H Haering
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

4.  Degradation of misfolded protein in the cytoplasm is mediated by the ubiquitin ligase Ubr1.

Authors:  Frederik Eisele; Dieter H Wolf
Journal:  FEBS Lett       Date:  2008-11-27       Impact factor: 4.124

5.  The self-perpetuating tau truncation circle.

Authors:  Norbert Zilka; Branislav Kovacech; Peter Barath; Eva Kontsekova; Michal Novák
Journal:  Biochem Soc Trans       Date:  2012-08       Impact factor: 5.407

6.  Altered activity, social behavior, and spatial memory in mice lacking the NTAN1p amidase and the asparagine branch of the N-end rule pathway.

Authors:  Y T Kwon; S A Balogh; I V Davydov; A S Kashina; J K Yoon; Y Xie; A Gaur; L Hyde; V H Denenberg; A Varshavsky
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

7.  Control of protein quality and stoichiometries by N-terminal acetylation and the N-end rule pathway.

Authors:  Anna Shemorry; Cheol-Sang Hwang; Alexander Varshavsky
Journal:  Mol Cell       Date:  2013-04-18       Impact factor: 17.970

8.  BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

Authors:  Nicholas J Donato; Ji Yuan Wu; Jonathan Stapley; Gary Gallick; Hui Lin; Ralph Arlinghaus; Moshe Talpaz
Journal:  Blood       Date:  2003-01-15       Impact factor: 22.113

9.  Resolution of chiasmata in oocytes requires separase-mediated proteolysis.

Authors:  Nobuaki R Kudo; Katja Wassmann; Martin Anger; Melina Schuh; Karin G Wirth; Huiling Xu; Wolfgang Helmhart; Hiromi Kudo; Michael McKay; Bernard Maro; Jan Ellenberg; Peter de Boer; Kim Nasmyth
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

Review 10.  Is malfunction of the ubiquitin proteasome system the primary cause of alpha-synucleinopathies and other chronic human neurodegenerative disease?

Authors:  Lynn Bedford; David Hay; Simon Paine; Nooshin Rezvani; Maureen Mee; James Lowe; R John Mayer
Journal:  Biochim Biophys Acta       Date:  2008-10-25
View more
  3 in total

1.  C-terminal glutamine acts as a C-degron targeted by E3 ubiquitin ligase TRIM7.

Authors:  Yawei Ru; Xiaojie Yan; Bing Zhang; Lili Song; Qiqi Feng; Chen Ye; Zhili Zhou; Zhenzhen Yang; Yao Li; Zhenjian Zhang; Qianqian Li; Wenyi Mi; Cheng Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-22       Impact factor: 12.779

2.  Molecular basis for ubiquitin ligase CRL2FEM1C-mediated recognition of C-degron.

Authors:  Xiaojie Yan; Xiaolu Wang; Yao Li; Mengqi Zhou; Yanjun Li; Lili Song; Wenyi Mi; Jinrong Min; Cheng Dong
Journal:  Nat Chem Biol       Date:  2021-01-04       Impact factor: 15.040

3.  Multiple E3s promote the degradation of histone H3 variant Cse4.

Authors:  Haili Cheng; Xin Bao; Xin Gan; Shiwen Luo; Hai Rao
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.